Pluri Inc. (PLUR)
NASDAQ
Closed
Sep 21, 2026
Day's Range
1.0152 wk Range
1.01Overview - PLUR - Pluri Inc.
Key Statistics
Valuation
Enterprise Value
43.61M
P/E (Trailing)
‪-0.35‬
P/E (Forward)
‪-0.66‬
PEG Ratio
‪0.0085‬
Price / Sales (TTM)
‪14.11‬
Price / Book
‪-0.97‬
EV / EBITDA
‪-1.70‬
Profitability
Gross Margin
‪33.53%‬
Profit Margin
‪48.95%‬
Operating Margin
‪-3,913.77%‬
Return on Assets
‪-51.23%‬
Return on Equity
‪2,610.75%‬
Ownership
Shares Outstanding
10.43M
Float
4.44M
Short % of Shares Outstanding
‪0.77%‬
Held by Insiders
‪42.16%‬
Held by Institutions
‪10.96%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪1.71‬
200-Day Avg
‪2.80‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
1 analysts
Market Cap - PLUR - Pluri Inc.
Peers - PLUR - Pluri Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- PLURNASDAQPluri Inc.14.98MMarket Cap-295.20%52-week change-0.35P/E (Trailing)‪48.95%‬Profit Margin
- ARGXNASDAQArgenx SE61.58BMarket Cap+25.27%52-week change37.92P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.32.05BMarket Cap-91.57%52-week change41.68P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE24.13BMarket Cap-2.77%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S15.57BMarket Cap+17.02%52-week change18.34P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.02BMarket Cap+22.62%52-week change-17.62P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.12.37BMarket Cap+15.64%52-week change172.81P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - PLUR - Pluri Inc.
About
Pluri Inc. is a biotechnology company focused on the research, development, manufacturing, and commercialization of cell-based products and related technologies. The company uses its proprietary three-dimensional cell expansion platform to support scalable cell production for applications across regenerative medicine,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
